Sex and gender perspectives in colorectal cancer
Iosune Baraibar(Breast Cancer Research Foundation), Elena Élez(Vall d'Hebron Hospital Universitari)
Cited by 103
Related Papers
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2021|411
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
|The Lancet|2023|319
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
|Molecular Cancer|2018|306